Added to YB: 2019-06-15
Pitch date: 2019-06-15
BCRX [bearish]
BioCryst Pharmaceuticals, Inc.
-134.5%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases.
Market Cap
$2.1B
Pitch Price
$3.42
Price Target
N/A
Dividend
N/A
EV/EBITDA
5.86
P/E
-4.83
EV/Sales
2.72
Sector
Biotechnology
Category
N/A
Show full summary:
BIOCRYST PHARMACEUTICALS INC BCRX
A summary for this pitch has not been created yet.
Read full article (0 min)